KQ Labs accelerator program is for exciting early-stage start-ups using data as a core part of their business model to improve human health.
At KQ Labs, they support innovative early-stage data-driven health start-ups to validate their ideas and put their exciting companies on the path to receive further investment.
Benefits of KQ Labs accelerator program
- A tailored and customised five-month programme focused on data-driven health;
- Specialised investor introductions;
- Introductions to major corporates, especially pharma;
- Mentoring opportunities with a hand-picked network of experts;
- £40k funding in the form of a convertible loan.
- The programme kicks off with an intensive three days of introductory workshops for the selected startup teams, which will run at the end of October.
- This is followed by a five-month programme of once-weekly workshops (generally on Wednesdays) and seminars covering topics such as fundraising, pitch training, business models, team building and leadership, scaling, intellectual property, regulatory aspects, market access (UK and internationally), and various aspects of access to data including ethics.
- They will also facilitate introductions and mentoring with a hand-picked network of experts, investors and corporates.
- The programme culminates in a Demo Day in March, where the startups pitch their ideas to potential investors and partners, including VCs, angel investors and pharma.
Who is eligible?
The program is aimed at early-stage data-driven health entrepreneurs looking for support to validate their ideas and develop their business goals in a supportive and enriching environment. They are looking for start-ups who have:
- A focus on areas that have the potential to have a significant impact on health, and where the use of data is a core part of the business model;
- Two or more founders or team members;
- A Minimum Viable Product, prototype or proof of concept;
- An early-stage company (pre-series A);
- A team based in the UK;
- The start-up’s legal entity must be UK-based.